Alfasigma to Buy Liver Disease Drugmaker Intercept ...Middle East

Italy's Alfasigma agreed on Tuesday to buy drugmaker Intercept for $794 million as it aims to expand its treatment portfolio in liver diseases and digestive system disorders. Reuters Health Information

Hence then, the article about alfasigma to buy liver disease drugmaker intercept was published today ( Wednesday 27/09/2023 - 09:52 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alfasigma to Buy Liver Disease Drugmaker Intercept )

Also on site :

• My Wife Made an Unusual Sound During Sex. At First, I Didn’t Mind. Then the Bloodcurdling Reality Hit Me.
• DataRepublican Schools Clown Who Doxxed 'Bully' Cynical Publius
• These Celebrities Are Not Welcome at the 2026 Oscars (and Why)